04Jun
Cannabis-Derived Ingredients in FDA-Regulated Products: More Questions than Answers at FDA’s May 2019 Public Hearing
As most folks with any interest in the burgeoning cannabidiol (CBD) industry likely know, on May 31, 2019, the Food and Drug Administration held a public hearing “to obtain scientific data and information about the safety, manufacturing, product...
By:
Mintz - Consumer Product Safety Viewpoints
Related
In 1832, South Carolina adopted common-law marriage by way of a court decision, holding the union wa...
Read More >
In a recent summary order in an ERISA LTD benefits case, the Second Circuit Court of Appeals rejecte...
Read More >
This week, the United States Supreme Court issued a decision in Kisor v. Wilkie, a case seeking to o...
Read More >
Earlier this month, Governor Pritzker signed into law SB 1557, revising the Recreational Cannabis La...
Read More >
Presented below is our summary of significant Internal Revenue Service (IRS) guidance and relevant t...
Read More >
On June 26, 2019, the Toledo City Council approved Ordinance 173-19, titled “Pay Equity Act to Proh...
Read More >